CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 2.32
  • +0.02+0.87%
Market Closed May 15 15:00 CST
11.46BMarket Cap-14591P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-20.25%17.49B
0.17%49.7B
8.88%41.19B
21.13%33.43B
20.38%21.93B
0.07%49.62B
6.60%37.83B
20.40%27.6B
42.77%18.21B
20.35%49.58B
Operating revenue
-15.16%441.88M
12.19%1.92B
22.46%1.48B
26.46%1.05B
22.63%520.83M
-2.54%1.71B
-7.41%1.21B
-0.98%830.33M
-16.03%424.71M
5.42%1.76B
Other operating revenue
-15.16%441.88M
12.19%1.92B
22.46%1.48B
26.46%1.05B
22.63%520.83M
-2.54%1.71B
-7.41%1.21B
-0.98%830.33M
-16.03%424.71M
5.42%1.76B
Special items of total operating revenue
-19.50%1.77B
-26.43%7.46B
-33.71%5.33B
-26.04%3.86B
-15.79%2.19B
-2.94%10.14B
4.31%8.04B
1.83%5.22B
11.19%2.61B
-1.84%10.44B
Total operating cost
-19.14%17.61B
4.39%51.54B
12.08%41.62B
23.88%33.7B
20.76%21.78B
0.34%49.37B
5.95%37.13B
21.18%27.21B
45.51%18.03B
22.83%49.2B
Operating cost
-37.67%665.96M
7.38%3.73B
18.16%2.93B
25.93%2.08B
31.75%1.07B
18.49%3.47B
16.36%2.48B
24.30%1.65B
23.70%810.97M
2.14%2.93B
Operating tax surcharges
33.25%25.78M
7.14%81.52M
-4.27%52.8M
-2.80%37.11M
-9.42%19.34M
8.40%76.08M
9.30%55.16M
18.36%38.18M
25.11%21.35M
35.02%70.19M
Asset Impairment Loss
----
1,533.26%2.68B
--454.38M
----
----
-84.67%163.94M
----
----
----
267.95%1.07B
Special items of total operating cost
----
----
----
----
----
-3,475.79%-1.86B
51.01%-19.43M
70.18%-10.36M
88.91%-5.97M
76.89%-52.11M
Other net revenue
0
0
0
0
0
0
0
0
0
0
Operating profit
-181.33%-122.18M
-849.56%-1.84B
-161.25%-428.06M
-169.12%-271.56M
-17.16%150.23M
-35.74%245.59M
57.94%698.85M
-16.66%392.9M
-50.31%181.35M
-66.60%382.2M
Add:Non operating Income
-33.55%5.85M
-53.50%10.78M
154.51%9.3M
352.93%8.35M
743.91%8.8M
165.32%23.18M
-53.98%3.65M
-19.26%1.84M
32.94%1.04M
-97.68%8.74M
Less:Non operating expense
19.22%10.54M
-13.77%37.93M
-17.88%27.97M
-16.10%21.01M
-31.23%8.84M
-8.00%43.99M
4.99%34.05M
44.05%25.04M
47.54%12.85M
-32.60%47.82M
Total profit
-184.47%-126.87M
-931.04%-1.87B
-166.83%-446.73M
-176.88%-284.22M
-11.41%150.2M
-34.49%224.78M
59.92%668.45M
-18.99%369.71M
-52.51%169.54M
-76.33%343.12M
Less:Income tax cost
-30.74%45.34M
-105.19%-586.5M
-112.00%-27.29M
114.20%89.95M
159.56%65.47M
46.78%-285.84M
198.30%227.47M
131.31%41.99M
-47.86%-109.92M
-261.99%-537.09M
Net profit
SL-172.21M
SL-1.28B
SL-419.44M
SL-374.16M
-69.68%84.73M
-41.99%510.62M
-32.09%440.98M
-44.50%327.71M
-35.21%279.46M
-21.26%880.22M
Net profit from continuing operation
-303.24%-172.21M
-350.97%-1.28B
-195.11%-419.44M
-214.17%-374.16M
-69.68%84.73M
-41.99%510.62M
-32.09%440.98M
-44.50%327.71M
-35.21%279.46M
-21.26%880.22M
Less:Minority Profit
-308.30%-82.34M
-366.20%-629.74M
-201.51%-206.44M
-223.22%-186.77M
-70.09%39.53M
-42.23%236.57M
-31.50%203.37M
-45.02%151.57M
-36.10%132.16M
-23.83%409.5M
Net profit of parent company owners
-298.82%-89.88M
-337.82%-651.76M
-189.64%-213M
-206.39%-187.4M
-69.31%45.21M
-41.78%274.05M
-32.59%237.61M
-44.05%176.14M
-34.39%147.3M
-18.88%470.71M
Earning per share
Basic earning per share
-282.00%-0.0182
-316.67%-0.13
-189.60%-0.0431
-205.56%-0.038
-66.67%0.01
-40.00%0.06
-32.54%0.0481
-43.75%0.036
-33.92%0.03
-16.67%0.1
Diluted earning per share
-282.00%-0.0182
-316.67%-0.13
-189.60%-0.0431
-205.56%-0.038
-66.67%0.01
-40.00%0.06
-32.54%0.0481
-43.75%0.036
-33.92%0.03
-16.67%0.1
Other composite income
-84.05%90.73M
130.65%835.74M
101.42%42.96M
129.07%446.57M
126.86%568.98M
-239.31%-2.73B
-262.97%-3.02B
-908.15%-1.54B
-800.38%-2.12B
672.41%1.96B
Other composite income of parent company owners
-84.01%46.37M
130.67%426.33M
101.40%21.61M
129.13%228.22M
126.84%289.88M
-239.27%-1.39B
-262.91%-1.54B
-908.09%-783.4M
-800.09%-1.08B
672.35%998.06M
Other composite income of minority owners
-84.10%44.36M
130.63%409.41M
101.44%21.35M
129.00%218.35M
126.88%279.1M
-239.35%-1.34B
-263.03%-1.48B
-908.22%-752.81M
-800.67%-1.04B
672.47%959.13M
Total composite income
-112.46%-81.48M
79.88%-445.76M
85.42%-376.48M
105.99%72.41M
135.55%653.71M
-178.10%-2.22B
-203.09%-2.58B
-254.82%-1.21B
-350.60%-1.84B
265.65%2.84B
Total composite income of parent company owners
-112.99%-43.51M
79.80%-225.43M
85.31%-191.39M
106.72%40.82M
135.93%335.08M
-175.98%-1.12B
-200.38%-1.3B
-247.48%-607.26M
-346.23%-932.67M
261.85%1.47B
Total composite income of minority owners
-111.92%-37.97M
79.97%-220.33M
85.52%-185.09M
105.25%31.59M
135.16%318.63M
-180.37%-1.1B
-206.02%-1.28B
-263.02%-601.24M
-355.27%-906.32M
269.83%1.37B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
China Audit Asia Pacific Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Asia Pacific Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -20.25%17.49B0.17%49.7B8.88%41.19B21.13%33.43B20.38%21.93B0.07%49.62B6.60%37.83B20.40%27.6B42.77%18.21B20.35%49.58B
Operating revenue -15.16%441.88M12.19%1.92B22.46%1.48B26.46%1.05B22.63%520.83M-2.54%1.71B-7.41%1.21B-0.98%830.33M-16.03%424.71M5.42%1.76B
Other operating revenue -15.16%441.88M12.19%1.92B22.46%1.48B26.46%1.05B22.63%520.83M-2.54%1.71B-7.41%1.21B-0.98%830.33M-16.03%424.71M5.42%1.76B
Special items of total operating revenue -19.50%1.77B-26.43%7.46B-33.71%5.33B-26.04%3.86B-15.79%2.19B-2.94%10.14B4.31%8.04B1.83%5.22B11.19%2.61B-1.84%10.44B
Total operating cost -19.14%17.61B4.39%51.54B12.08%41.62B23.88%33.7B20.76%21.78B0.34%49.37B5.95%37.13B21.18%27.21B45.51%18.03B22.83%49.2B
Operating cost -37.67%665.96M7.38%3.73B18.16%2.93B25.93%2.08B31.75%1.07B18.49%3.47B16.36%2.48B24.30%1.65B23.70%810.97M2.14%2.93B
Operating tax surcharges 33.25%25.78M7.14%81.52M-4.27%52.8M-2.80%37.11M-9.42%19.34M8.40%76.08M9.30%55.16M18.36%38.18M25.11%21.35M35.02%70.19M
Asset Impairment Loss ----1,533.26%2.68B--454.38M---------84.67%163.94M------------267.95%1.07B
Special items of total operating cost ---------------------3,475.79%-1.86B51.01%-19.43M70.18%-10.36M88.91%-5.97M76.89%-52.11M
Other net revenue 0000000000
Operating profit -181.33%-122.18M-849.56%-1.84B-161.25%-428.06M-169.12%-271.56M-17.16%150.23M-35.74%245.59M57.94%698.85M-16.66%392.9M-50.31%181.35M-66.60%382.2M
Add:Non operating Income -33.55%5.85M-53.50%10.78M154.51%9.3M352.93%8.35M743.91%8.8M165.32%23.18M-53.98%3.65M-19.26%1.84M32.94%1.04M-97.68%8.74M
Less:Non operating expense 19.22%10.54M-13.77%37.93M-17.88%27.97M-16.10%21.01M-31.23%8.84M-8.00%43.99M4.99%34.05M44.05%25.04M47.54%12.85M-32.60%47.82M
Total profit -184.47%-126.87M-931.04%-1.87B-166.83%-446.73M-176.88%-284.22M-11.41%150.2M-34.49%224.78M59.92%668.45M-18.99%369.71M-52.51%169.54M-76.33%343.12M
Less:Income tax cost -30.74%45.34M-105.19%-586.5M-112.00%-27.29M114.20%89.95M159.56%65.47M46.78%-285.84M198.30%227.47M131.31%41.99M-47.86%-109.92M-261.99%-537.09M
Net profit SL-172.21MSL-1.28BSL-419.44MSL-374.16M-69.68%84.73M-41.99%510.62M-32.09%440.98M-44.50%327.71M-35.21%279.46M-21.26%880.22M
Net profit from continuing operation -303.24%-172.21M-350.97%-1.28B-195.11%-419.44M-214.17%-374.16M-69.68%84.73M-41.99%510.62M-32.09%440.98M-44.50%327.71M-35.21%279.46M-21.26%880.22M
Less:Minority Profit -308.30%-82.34M-366.20%-629.74M-201.51%-206.44M-223.22%-186.77M-70.09%39.53M-42.23%236.57M-31.50%203.37M-45.02%151.57M-36.10%132.16M-23.83%409.5M
Net profit of parent company owners -298.82%-89.88M-337.82%-651.76M-189.64%-213M-206.39%-187.4M-69.31%45.21M-41.78%274.05M-32.59%237.61M-44.05%176.14M-34.39%147.3M-18.88%470.71M
Earning per share
Basic earning per share -282.00%-0.0182-316.67%-0.13-189.60%-0.0431-205.56%-0.038-66.67%0.01-40.00%0.06-32.54%0.0481-43.75%0.036-33.92%0.03-16.67%0.1
Diluted earning per share -282.00%-0.0182-316.67%-0.13-189.60%-0.0431-205.56%-0.038-66.67%0.01-40.00%0.06-32.54%0.0481-43.75%0.036-33.92%0.03-16.67%0.1
Other composite income -84.05%90.73M130.65%835.74M101.42%42.96M129.07%446.57M126.86%568.98M-239.31%-2.73B-262.97%-3.02B-908.15%-1.54B-800.38%-2.12B672.41%1.96B
Other composite income of parent company owners -84.01%46.37M130.67%426.33M101.40%21.61M129.13%228.22M126.84%289.88M-239.27%-1.39B-262.91%-1.54B-908.09%-783.4M-800.09%-1.08B672.35%998.06M
Other composite income of minority owners -84.10%44.36M130.63%409.41M101.44%21.35M129.00%218.35M126.88%279.1M-239.35%-1.34B-263.03%-1.48B-908.22%-752.81M-800.67%-1.04B672.47%959.13M
Total composite income -112.46%-81.48M79.88%-445.76M85.42%-376.48M105.99%72.41M135.55%653.71M-178.10%-2.22B-203.09%-2.58B-254.82%-1.21B-350.60%-1.84B265.65%2.84B
Total composite income of parent company owners -112.99%-43.51M79.80%-225.43M85.31%-191.39M106.72%40.82M135.93%335.08M-175.98%-1.12B-200.38%-1.3B-247.48%-607.26M-346.23%-932.67M261.85%1.47B
Total composite income of minority owners -111.92%-37.97M79.97%-220.33M85.52%-185.09M105.25%31.59M135.16%318.63M-180.37%-1.1B-206.02%-1.28B-263.02%-601.24M-355.27%-906.32M269.83%1.37B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --China Audit Asia Pacific Certified Public Accountants (Special General Partnership)------China Audit Asia Pacific Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg